EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers

Soljee Yoon, Hye Yun Kim, Sohui Park, Minhae Cha, Kyeonghwan Kim, Songmin Lee, JiMin Kim, Saeyun Bhang, YoungSoo Kim iD

Angewandte Chemie International Edition · 2024

DOI: 10.1002/anie.202411942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Soljee Yoon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea. Hauptthemen laut MEDLINE: tau Proteins, Tauopathies, Drug Discovery. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Dementia Research Center, National Research Foundation of Korea, Amyloid Solution.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comprehending early amyloidogenesis is essential for the development of effective therapeutic strategies. In tauopathies like Alzheimer's disease (AD), the abnormal accumulation of tau protein is initiated by pathological tau seeds. Mounting evidence implies that the microtubule binding domain, consisting of three to four repeats, plays a pivotal role in this process, yet the exact region driving the formation of pathogenic species needs to be further scrutinized. Here, we chemically synthesized individual tau repeats to identify those exhibiting pathogenic prion‐like characteristics. Notably, repeat 3 (R3) displayed a remarkable propensity to polymerize, form toxic filaments, and induce cognitive impairment, even in the absence of an aggregation‐promoting inducer, highlighting its physiological relevance. Additionally, oligomeric R3 was identified as a particularly pathological form, prompting the establishment of a screening platform. Through screening, tolcapone was found to possess therapeutic efficacy against pathological tau aggregates in PS19 transgenic mice. This screening platform provides a valuable avenue for identifying compounds that selectively interact with peptides implicated in the progression of tauopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsTauopathiesDrug DiscoveryAnimalsHumansMiceMice, Transgenic

Stichwörter der Autor:innen

AggregationAlzheimer's diseaseHigh-throughput screeningPeptidesTau protein

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Department of Integrative Biotechnology, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.
  • Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.
  • Integrated Science and Engineering Division, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.
  • Department of Psychiatry, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
  • POSTECH-Yonsei Campus, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk, 37673, Republic of Korea.
  • Amyloid Solution inc., 58 Pangyo-ro 255 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13486, Republic of Korea.

ORCID-Profile: YoungSoo Kim

Förderung

  • Korea Dementia Research Center
  • National Research Foundation of Korea
  • Amyloid Solution

Zitieren

APA

Yoon, S., Kim, H. Y., Park, S., Cha, M., Kim, K., Lee, S., Kim, J., Bhang, S., & Kim, Y. (2024). Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202411942

Vancouver

Yoon S, Kim HY, Park S, Cha M, Kim K, Lee S, et al. Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202411942

BibTeX
@article{Yoon2024,
  author = {Yoon, Soljee and Kim, Hye Yun and Park, Sohui and Cha, Minhae and Kim, Kyeonghwan and Lee, Songmin and Kim, JiMin and Bhang, Saeyun and Kim, YoungSoo},
  title = {Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  doi = {10.1002/anie.202411942}
}
Kostenlos starten →